Concepedia

Eliza Shulman

ES

7

Publications

337

Citations

7

H-Index

1995

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Massachusetts General Hospital

Harvard University

Eliza Shulman is an author at National Cancer Institute specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

1995–2023

7

Publications

7

Enhancing Efficacy of Recombinant Anticancer Vaccines With Prime/Boost Regimens That Use Two Different Vectors

Kari R. Irvine, Ronald S. Chamberlain, Eliza Shulman et al. · JNCI Journal of the National Cancer Institute · 1997 · 155 citations · Full text

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses.

Barbra Jill McCabe, Kari R. Irvine, Michael I. Nishimura et al. · PubMed · 1995 · 49 citations

, , +18

Implementation of a virtual and in-person hybrid hospital-at-home model in two geographically separate regions utilizing a single command center: a descriptive cohort study

Margaret R. Paulson, Eliza Shulman, Ajani N. Dunn et al. · BMC Health Services Research · 2023 · 44 citations · Full text

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

Kari R. Irvine, Maria R. Parkhurst, Eliza Shulman et al. · PubMed · 1999 · 38 citations

, , +15

Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer

Ryan David Nipp, Eliza Shulman, Melissa H Smith et al. · BMC Cancer · 2022 · 22 citations · Full text

Rows per page

1–5 of 7